Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study
- Creator: Shapiro, Jeremy D. , Thavaneswaran, Subotheni , Tebbutt, Niall C. , Price, Timothy J. , Khasraw, Mustafa , Van Hazel, Guy A. , Waring, Paul M. , Tejpar, Sabine , Simes, John , Gebski, Val J. , Desai, Jayesh , Segelov, Eva , Underhill, Craig R. , Robledo, Kristy P. , Karapetis, Chistos S. , Day, Fiona L. , Nott, Louise M. , Jefford, Michael , Chantrill, Lorraine A. , Pavlakis, Nick
- Resource Type: journal article
- Date: 2018
Current opinion on optimal treatment for colorectal cancer
- Creator: Price, Timothy J. , Segelov, Eva , Shapiro, Jeremy D. , Burge, Matthew , Haller, Daniel G. , Ackland, Stephen P. , Tebbutt, Niall C. , Karapetis, Christos S. , Pavlakis, Nick , Sobrero, Alberto F. , Cunningham, David
- Resource Type: journal article
- Date: 2013